0 Ratings

ID

32391

Description

Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00457574

Link

https://clinicaltrials.gov/show/NCT00457574

Keywords

  1. 10/29/18 10/29/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

October 29, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Solid Tumors and Lymphomas NCT00457574

    Eligibility Solid Tumors and Lymphomas NCT00457574

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    patients must have a histologically or cytologically confirmed solid tumor or lymphoma
    Description

    Solid Neoplasm | Lymphoma

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0280100
    UMLS CUI [2]
    C0024299
    no limitations on allowable type and amount of prior therapy.
    Description

    Limitation Absent Prior Therapy

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0449295
    UMLS CUI [1,2]
    C0332197
    UMLS CUI [1,3]
    C1514463
    patients must have a life expectancy of greater than 8 weeks
    Description

    Life Expectancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    patients must have normal organ and marrow function
    Description

    Organ function | Bone Marrow function

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0678852
    UMLS CUI [2,1]
    C0005953
    UMLS CUI [2,2]
    C0031843
    patients must be willing to submit blood sampling for planned pk analysis
    Description

    Blood sampling Pharmacokinetic aspects

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0005834
    UMLS CUI [1,2]
    C0031328
    patients must have the ability to understand and willingness to sign a written informed consent form
    Description

    Informed Consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    no other agents or therapies administered with the intent to treat malignancy
    Description

    Pharmaceutical Preparations Other Cancer treatment | Cancer treatment Other

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0205394
    UMLS CUI [1,3]
    C0920425
    UMLS CUI [2,1]
    C0920425
    UMLS CUI [2,2]
    C0205394
    patients with prior exposure to gmx1777 or gmx1778
    Description

    Exposure to GMX1777 | Exposure to GMX 1778

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0332157
    UMLS CUI [1,2]
    C2346839
    UMLS CUI [2,1]
    C0332157
    UMLS CUI [2,2]
    C2713488
    uncontrolled, intercurrent illness
    Description

    Comorbidity Uncontrolled

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0009488
    UMLS CUI [1,2]
    C0205318
    pregnant women and women who are breast feeding
    Description

    Pregnancy | Breast Feeding

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147

    Similar models

    Eligibility Solid Tumors and Lymphomas NCT00457574

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Solid Neoplasm | Lymphoma
    Item
    patients must have a histologically or cytologically confirmed solid tumor or lymphoma
    boolean
    C0280100 (UMLS CUI [1])
    C0024299 (UMLS CUI [2])
    Limitation Absent Prior Therapy
    Item
    no limitations on allowable type and amount of prior therapy.
    boolean
    C0449295 (UMLS CUI [1,1])
    C0332197 (UMLS CUI [1,2])
    C1514463 (UMLS CUI [1,3])
    Life Expectancy
    Item
    patients must have a life expectancy of greater than 8 weeks
    boolean
    C0023671 (UMLS CUI [1])
    Organ function | Bone Marrow function
    Item
    patients must have normal organ and marrow function
    boolean
    C0678852 (UMLS CUI [1])
    C0005953 (UMLS CUI [2,1])
    C0031843 (UMLS CUI [2,2])
    Blood sampling Pharmacokinetic aspects
    Item
    patients must be willing to submit blood sampling for planned pk analysis
    boolean
    C0005834 (UMLS CUI [1,1])
    C0031328 (UMLS CUI [1,2])
    Informed Consent
    Item
    patients must have the ability to understand and willingness to sign a written informed consent form
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Pharmaceutical Preparations Other Cancer treatment | Cancer treatment Other
    Item
    no other agents or therapies administered with the intent to treat malignancy
    boolean
    C0013227 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    C0920425 (UMLS CUI [1,3])
    C0920425 (UMLS CUI [2,1])
    C0205394 (UMLS CUI [2,2])
    Exposure to GMX1777 | Exposure to GMX 1778
    Item
    patients with prior exposure to gmx1777 or gmx1778
    boolean
    C0332157 (UMLS CUI [1,1])
    C2346839 (UMLS CUI [1,2])
    C0332157 (UMLS CUI [2,1])
    C2713488 (UMLS CUI [2,2])
    Comorbidity Uncontrolled
    Item
    uncontrolled, intercurrent illness
    boolean
    C0009488 (UMLS CUI [1,1])
    C0205318 (UMLS CUI [1,2])
    Pregnancy | Breast Feeding
    Item
    pregnant women and women who are breast feeding
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial